BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Growing Pains at BIO as Price Control Debate Heats Up in Washington and Within the Industry

  Multiple reports suggest an exodus of BIO team members over price control issues. BIO reorganized its leadership structure to provide what was expected to be “long-term stability for the organization.”

  September 1, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  VectivBio Expands Rare Disease Pipeline with Comet Therapeutics Acquisition

  Adding to its list of achievements, on Tuesday the Swiss biotech announced it is acquiring Comet Therapeutics.

  September 1, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  Janssen Wins FDA Approval for Long-Acting Schizophrenia Drug Invega Hafyera

  FDA greenlit Janssen’s Invega Hafyera, the first long-acting antipsychotic drug of its kind that provides six months’ control of symptoms with a single dose.

  September 1, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Kyowa Kirin: Tilting at Gender Equality at the Highest Levels

  Between April 2020 and today, the executive board of Kyowa Kiran North America (KKNA) has grown from being predominantly male to a 50/50 gender split.

  September 1, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Moderna COVID Vaccine Stimulates Twice the Antibody Response as Pfizer-BioNTech

  Belgium researchers compared the Moderna and Pfizer-BioNTech COVID-19 vaccines and found that the Moderna jabs generated twice the antibodies than the Pfizer-BioNTech vaccine.

  September 1, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  COVID-19 Update: Booster Effectiveness, Asymptomatic Cases and Vaccination Spike

  New data is coming out every day about COVID-19 and the body’s response to vaccines. Here’s a look at some of the top stories.

  September 1, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Astellas Pauses Dosing of Gene Therapy After Liver-Linked Concerns

  The company announced it paused the screening and dosing of an investigational gene therapy for patients with XLMTM following a serious adverse event report in a trial participant.

  September 1, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Global Roundup: VectivBio Acquires Comet Therapeutics to Expand Rare Disease Pipeline

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  September 1, 2021

   · 

  5 min read

   · 

  Alex Keown
• 

  Business

  Many Cytokine Space Parallels Drawn by Asher Bio’s Series B

  Asher Bio began two years ago and raised $55 million in a Series A financing round this March to take forward a series of engineered cytokines that aim to eliminate both the toxicities and the loss of efficacy in immunotherapy.

  September 1, 2021

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Business

  AstraZeneca and Thermo Fisher Partner to Match Patients to Precision Therapies

  The duo’s mission is to identify more patients who could benefit from precision medicines by deploying more CDx tests to healthcare providers.

  September 1, 2021

   · 

  3 min read

   · 

  Heather McKenzie